Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
Application of innovative molecular profiling techniques to improve diagnosis of paediatric central nervous system tumours and develop an accredited Australasian molecular profiling service
Protocol ID
ACCT009 (AIM BRAIN PROject)
Disease (Sub Disease)
Central Nervous System Tumours
Diagnosis Stage
New Diagnosis
Relapse
Location
NSW, QLD, VIC, WA, SA, NZ, TAS
Sponsor
Australian and New Zealand Children's Haematology Oncology Group
Trial Status
Open
Sites
The Children's Hospital at Westmead
John Hunter Children's Hospital
Monash Children's Hospital
Perth Children's Hospital
Queensland Children's Hospital
Sydney Children's Hospital
Royal Children's Hospital
Women's & Children's Hospital
Royal Hobart Hospital
Christchurch Hospital
Starship Hospital
Study Type
Diagnosis
Phase
Not applicable
Age Eligibility
up to 21 years
ANZCTR
ACTRN12618000006246
Back to Registry
Study Title Application of innovative molecular profiling techniques to improve diagnosis of paediatric central nervous system tumours and develop an accredited Australasian molecular profiling service
Protocol ID ACCT009 (AIM BRAIN PROject)
Disease (Sub Disease) Central Nervous System Tumours
Diagnosis Stage New Diagnosis
Relapse
Location NSW / QLD / VIC / WA / SA / NZ / TAS
Sponsor Australian and New Zealand Children's Haematology Oncology Group
Links https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=374062&isReview=true
Trial Status Open
Trial Open Date 27/03/2018
Sites The Children's Hospital at Westmead / John Hunter Children's Hospital / Monash Children's Hospital / Perth Children's Hospital / Queensland Children's Hospital / Sydney Children's Hospital / Royal Children's Hospital / Women's & Children's Hospital / Royal Hobart Hospital / Christchurch Hospital / Starship Hospital
Study Type Diagnosis
Phase Not applicable
Age Eligibility up to 21 years
ANZCTR ACTRN12618000006246